Evidence map›Paper›PMID 42605482›Full record

ArticleCureus2026

Radiation-Induced Pleomorphic Dermal Sarcoma of the Chest Wall 25 Years After Breast Cancer Radiotherapy: A Case Report and Literature Review.

Shamim Alikhail, Saban Secmeler, Saleha Alikhail, Saule Umurzakova

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shamim AlikhailOncology, Altınbaş University, Medical Park Bahçelievler Hospital, Istanbul, TUR.
Saban SecmelerMedical Oncology, Şanlıurfa Training and Research Hospital, Şanlıurfa, TUR.
Saleha AlikhailOrthopedics and Traumatology, Medical Park Bahçelievler Hospital, Istanbul, TUR.
Saule UmurzakovaNuclear Medicine, Medical Park Bahçelievler Hospital, Istanbul, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation-induced sarcoma (RIS) is a rare but aggressive long-term complication of radiotherapy. It typically develops within previously irradiated tissues after a prolonged latency period and is associated with poor prognosis because of its locally invasive behavior and high recurrence rates. Breast cancer survivors who receive adjuvant radiotherapy remain at risk for secondary malignancies, including sarcomas arising within the radiation field. We report the case of a 78-year-old woman who developed a progressively enlarging chest wall mass 25 years after mastectomy and adjuvant radiotherapy for breast cancer. Initial clinical and radiological findings raised concern for local recurrence; however, histopathological examination with immunohistochemistry confirmed a high-grade pleomorphic dermal sarcoma arising within the previously irradiated field. The patient initially received gemcitabine and docetaxel chemotherapy, but follow-up fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) demonstrated disease progression. She subsequently underwent extensive chest wall resection with pulmonary resection and prosthetic reconstruction, followed by palliative radiotherapy for metastatic disease. This case highlights the importance of maintaining a high index of suspicion for RIS in patients presenting with new lesions decades after radiotherapy, as early biopsy with histopathological and immunohistochemical evaluation is essential for accurate diagnosis and appropriate management.

Indexed as

breast cancermastectomyradiation-induced sarcomaradiotherapy (rt)secondary malignancy

Identifiers

PMID42605482
PMCPMC13477803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.